Market Capitalization | 2.6B |
Book Value | $7.09 |
Dividend Share | 1.4 |
Dividend Yield | 6.85% |
Earnings Per Share (EPS) | 1.9 |
PE Ratio | 10.76 |
PEG Ratio | 3.69 |
Wall Street Target Price | 22.0 |
Profit Margin | 40.97% |
Operating Margin TTM | 45.41% |
Return On Assets TTM | 5.73% |
Return On Equity TTM | 25.08% |
Revenue TTM | 583.9M |
Revenue Per Share TTM | 4.62 |
Quarterly Revenue Growth YOY | 6.3% |
Gross Profit TTM | 336.9M |
EBITDA | 350.3M |
Diluted Eps TTM | 1.9 |
Quarterly Earnings Growth YOY | 0.5 |
EPS Estimate Current Year | 1.89 |
EPS Estimate Next Year | 2.18 |
EPS Estimate Current Quarter | 0.51 |
EPS Estimate Next Quarter | 0.52 |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
A Spac I Acquisition Corp
$20.45
+0.0%
Gamida Cell Ltd
$20.45
+0.0%
Palladyne Ai Corp
$20.45
+0.0%
Keyarch Acquisition Corp
$20.45
+0.0%
Acorda Therapeutics, Inc.
$20.45
+0.0%
Connexa Sports Technologies Inc
$20.45
+0.0%
Semantix Inc
$20.45
+0.0%
Arrowroot Acquisition Corp-a
$20.45
+0.0%
Agios Pharmaceuticals, Inc.
$20.45
+0.0%